Found 4 matching trials
Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease PHASE3 To evaluate the long-term safety and tolerability of idalopirdine (Lu AE580...
Show More Learn More & Join Trial
Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease PHASE3 The purpose of this study is to compare 23 mg donepezil sustained release (...
Show More Learn More & Join Trial
A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type Dementia PHASE2 The purpose of this study is to compare 23 mg donepezil sustained release (...
Show More Location
Multiple Locations
Learn More & Join Trial
Open-Label Extension Study of 23 mg Donepezil SR in Participants With Moderate to Severe Alzheimer's Disease PHASE3 The purpose of this study is to evaluate the safety and efficacy of long-te...
Show More Location
Apex Research Institute
Learn More & Join Trial